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αTAT1 controls longitudinal 
spreading of acetylation 
marks from open microtubules 
extremities
Nathalie Ly1,*, Nadia Elkhatib1,*, Enzo Bresteau1, Olivier Piétrement2, Mehdi Khaled3, 
Maria M. Magiera4, Carsten Janke4, Eric Le Cam2, Andrew D. Rutenberg5,* & 
Guillaume Montagnac1,*
Acetylation of the lysine 40 of α-tubulin (K40) is a post-translational modification occurring in the 
lumen of microtubules (MTs) and is controlled by the α-tubulin acetyl-transferase αTAT1. How αTAT1 
accesses the lumen and acetylates α-tubulin there has been an open question. Here, we report that 
acetylation starts at open ends of MTs and progressively spreads longitudinally from there. We observed 
acetylation marks at the open ends of in vivo MTs re-growing after a Nocodazole block, and acetylated 
segments growing in length with time. Bias for MTs extremities was even more pronounced when using 
non-dynamic MTs extracted from HeLa cells. In contrast, K40 acetylation was mostly uniform along the 
length of MTs reconstituted from purified tubulin in vitro. Quantitative modelling of luminal diffusion of 
αTAT1 suggested that the uniform acetylation pattern observed in vitro is consistent with defects in the 
MT lattice providing lateral access to the lumen. Indeed, we observed that in vitro MTs are permeable 
to macromolecules along their shaft while cellular MTs are not. Our results demonstrate αTAT1 enters 
the lumen from open extremities and spreads K40 acetylation marks longitudinally along cellular MTs. 
This mode of tip-directed microtubule acetylation may allow for selective acetylation of subsets of 
microtubules.
Results and Discussion
Microtubules (MTs) are dynamic polymers composed of α β -tubulin dimers that assembled into hollow tubes. 
In most eukaryotic cells, MTs can undergo post-translational modifications (PTMs) that modify their proper-
ties and functions1. Acetylation of the lysine 40 of α -tubulin (K40) is a common PTM that is catalysed by the 
α -tubulin acetyl-transferase α TAT1 and is associated with stable, long-lived MTs2–4. Remarkably, K40 acetylation 
occurs in the lumen of MTs5,6 and is the only such PTM that we know of ref. 1. Supporting this, Szyk et al. recently 
used in vitro approaches to demonstrate that α TAT1 enters into and diffuses within the MT lumen7. However, 
Szyk et al. also suggested that fast diffusivity of α TAT1 leads to stochastic acetylation that occurs uniformly 
along the length of MTs. This was in marked contrast with earlier in vivo observations of discrete acetylated seg-
ments along MTs8–10 progressively elongating with time11. More recently, several groups have reported that the 
acetylated segments were predominately associated with the ends of MTs in vivo3,12. Thus, reported observations 
in vivo do not match the proposed model of uniformly distributed acetylated K40 marks based on experiments 
performed with in vitro MTs7.
To understand how acetylated K40 marks spreading occurs in vivo, we first analyzed acetylation dynamics in 
HeLa cells. In order to synchronize acetylation events, HeLa cells were subjected to complete MT depolymeri-
sation by a prolonged treatment with Nocodazole before being allowed to reassemble MTs after washing out the 
1Inserm U1170, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France. 2CNRS UMR8126, Gustave 
Roussy Institute, Université Paris-Saclay, Villejuif, France. 3CNRS UMR1186, Gustave Roussy Institute, Université 
Paris-Saclay, Villejuif, France. 4Institut Curie, CNRS UMR3348, PSL Research University, Centre Universitaire, Orsay, 
France. 5Department of Physics and Atmospheric Science, Dalhousie University, Halifax, NS, B3H 4R2, Canada. 
*These authors contributed equally to this work. Correspondence and requests for materials should be addressed to 
A.D.R. (email: andrew.rutenberg@Dal.Ca) or G.M. (email: guillaume.montagnac@gustave.roussy.fr)
Received: 19 July 2016
Accepted: 27 September 2016
Published: 18 October 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:35624 | DOI: 10.1038/srep35624
drug. As previously reported, we observed that acetylated K40 segments became detectable as early as 4 minutes 
after Nocodazole washout (Fig. 1A). The length of these acetylated segments progressively increased with time 
(Fig. 1A,B). Careful examination of the distribution of acetylated segments visible at 5 minutes after washout 
revealed that acetylated K40 marks were frequently, but not always, associated with MT extremities (Fig. 1C). 
Measurements of the fluorescence intensity distribution along the long axis of MTs also showed an average 
enrichment of acetylated K40 marks at the extremities of MTs (Fig. 1D).
Figure 1. Preferential acetylation of MT ends in vivo. (A) HeLa cells recovering from a Nocodazole block 
were fixed at the indicated time point after washing out the drug and then stained for K40 acetylated tubulin. 
Scale bar: 10 μ m. Insets corresponding to boxed regions are shown. Scale bar: 2 μ m. (B) Box plot of acetylated 
segments length at the indicated time points. Data are represented as mean ± S.E.M. (C) HeLa cells recovering 
from a Nocodazole block were fixed at 5 min after washing out the drug and stained for total tubulin (red) 
and K40 acetylated tubulin (green). Arrows indicate acetylated MT extremities. Scale bar: 2 μ m. (D) Average 
fluorescence intensity distribution of total tubulin staining (red) and K40 acetylated tubulin (green) along MTs 
as in C (see Experimental Procedures section). Data are represented as mean ± S.E.M.
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Our observation of a preference for acetylation at MT extremities agrees with earlier reports in vivo3,12 and 
suggests that α TAT1 accesses the lumen from the open ends of MTs and starts acetylating at those extremities. 
However, we also observed acetylation segments far from in vivo microtubule ends (Fig. 1C). While this might 
denote alternative lateral α TAT1 entry sites, we hypothesize instead that the extremely dynamic nature of micro-
tubules in vivo allows unacetylated extensions to grow past acetylated K40-positive extremities, leaving acetylated 
segments behind. Indeed, microtubule polymerization is much faster than acetylation spreading (in the order of 
~10 μ m/min while acetylated segments elongate only 2 μ m in 8 min as measured here). In this case, non-dynamic 
MTs should exhibit more acetylation segments at MT ends.
To test this hypothesis, we used α TAT1-knockdown HeLa cells extracted by a brief immersion in a MT stabi-
lizing buffer containing Triton. In these conditions, Taxol-stabilized ex vivo cellular MTs were readily visible and 
were negative for anti-acetylated K40 staining (Fig. 2A, upper panels). Ex vivo MTs were then incubated with 4 μ M 
of a recombinant catalytic domain of mouse α TAT1 (residues 1–193) in the presence of Acetyl-CoA for different 
time periods. Acetylated segments of MTs became visible as early as 30 s after addition of the recombinant enzyme 
and these segments were found to grow longer with time (Supplementary Figure 1), similarly to our in vivo  
observations. We then analysed the distribution of acetylated segments along MTs and observed that virtually 
all acetylated segments detected after a 2 min incubation period with the enzyme were located at the ends of 
individual MTs, with no detectable staining in other MT regions (Fig. 2A, lower panels). At the earliest time point 
analysed (30 s), small acetylated K40 segments were similarly found at the open extremity of MTs (Supplementary 
Figure 2). These tip-located acetylated segments grew in length with time, and by 15 min, most visible MTs were 
acetylated along their entire length (Supplementary Figure 2).
Figure 2. Longitudinal spreading of acetylated K40 marks from the ends of ex vivo MTs. (A) α TAT1-
knockdowned HeLa cells were Triton-extracted in the presence of Taxol and incubated for 2 min without (upper 
panels) or with 4 μ M recombinant α TAT1 (lower panels) before being fixed and stained for total (red) and 
acetylated tubulin (green). Scale bar: 10 μ m. Insets corresponding to boxed regions are shown. Scale bar: 2 μ m. 
(B) Average fluorescence intensity distribution of K40 acetylated tubulin along MTs (MTs tip at x = 1 μ m) after 
indicated time period incubation with 4 μ M recombinant α TAT1 as in A. Data are represented as mean. The 
S.E.M was omitted for clarity.
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Measurements of fluorescence intensity showed that while total tubulin staining was constant along the length 
of ex vivo MTs (Supplementary Figure 3A), a strong bias for the extremities was observed for the acetylated K40 
signal (Fig. 2B). We also noted a time-dependent progressive increase of staining intensity near the tips along with 
a progressive longitudinal (axial) spreading of acetylated K40 marks (Fig. 2B). We obtained similar results when 
using ex vivo MTs that were not stabilized with Taxol (Supplementary Figure 3B). In these latter conditions, the 
maximum intensity of acetylated K40 staining at the extremity was lower than in Taxol-stabilized ex vivo MTs. 
This may be due to a slow depolymerisation of MT ends leading to a partial loss of acetylation signal. Also, we 
performed acetylation assays on Taxol-stabilized ex vivo MTs by using a lower concentration (0.4 μ M) of recombi-
nant α TAT1. While the kinetics of acetylation was reduced, we observed the same preference for MT extremities 
and a progressive spreading of acetylated K40 marks from the ends (Supplementary Figure 3C). Together, our 
analysis unambiguously demonstrates that acetylation spreads progressively, longitudinally along ex vivo MTs, 
from their open extremities. Our data also suggest that acetylated segments observed far from MT ends in vivo 
most likely results from the dynamicity of MTs.
Because this conclusion disagrees with reports of uniform acetylation in vitro7, we next decided to analyse 
acetylation dynamics in Taxol-stabilized MTs assembled in vitro from purified HeLa cells tubulin dimers. Because 
HeLa tubulin dimers are poorly acetylated, no acetylated K40 marks were observed immediately after polymeri-
zation in vitro (Fig. 3A, left panel). However, after a 2 minutes incubation period in the presence of 4 μ M recombi-
nant α TAT1, we observed a punctuated acetylated K40 staining with an approximately random distribution along 
the length of MTs (Fig. 3A, middle panel). After a 4 minutes incubation period with the enzyme, the acetylated 
K40 signal was more intense but still distributed randomly along the length of the MTs. Careful examination 
revealed that extremities were often positive for acetylated K40 marks (Fig. 3A), though this was less striking than 
in vivo (Fig. 1C). The average fluorescence intensity distribution also showed a slight enrichment of acetylated 
K40 marks at open extremities as compare to other regions of MTs (Fig. 3C). We obtained similar results when 
using MTs assembled in vitro from purified bovine brain tubulin (not shown). In agreement with observations by 
Szyk et al., we concluded that acetylation occurs randomly (uniformly) along the length of in vitro MTs7. This is 
in marked contrast with our in vivo and ex vivo observations and therefore suggests that in vitro and cellular MTs 
may differ in their intrinsic properties.
Structural defects in the MT lattice, such as missing tubulin dimers or abrupt variations of protofilament 
number have been reported in in vitro assembled MTs13,14. It was recently proposed that stress accumulation at 
these lattice defects can results in the formation of larger damages that self-repair rapidly14,15. Indeed, transient 
opening of the MT lattice resulting from separation between protofilaments have been hypothesized to provide 
direct access to the MT lumen in a proposed “breathing model”16,17. To explore the hypothesis that the differences 
we observed were due to transient holes or defects on the sides of in vitro MTs, we have developed a mathematical 
model of α TAT1 diffusion within MTs followed by local acetylation by α TAT1. We have included both lateral 
access (due to holes), and access from MT extremities, followed by longitudinal diffusion as characterized by Szyk 
et al.7 (see Experimental Procedures section for details). When lateral access was not allowed, we observed that 
acetylation marks spreads longitudinally from the open MT extremities (Fig. 3D). This is in qualitative agreement 
with our ex vivo results. However, when lateral access was implemented in the model using α TAT1 residence 
times determined by Szyk et al.7, acetylation was uniform along the length of MTs (Fig. 3E). Thus, our modelling 
captures the qualitative difference between the mostly uniform acetylation in vitro and the progressive acetylation 
ex vivo and suggests that the shaft of in vitro reconstituted MTs is permeable to α TAT1 while the one of cellular 
MTs is not.
With our quantitative model of longitudinal diffusion, local acetylation, and possible lateral entry we observed 
that tip-directed acetylation is consistent with the measured luminal diffusivity of α TAT17, together with a mod-
erate acetylation rate and vanishing lateral entry. Conversely, we showed that uniform acetylation is consistent 
with rapid lateral entry (with respect to the times at which measurements are taken) independent of the other 
parameters. Are other parameterizations, perhaps without lateral entry, consistent with the observed phenom-
enology? Without lateral entry, tip-directed acetylation should be observed at earlier times in longer MT. The 
earliest reported uniform acetylation was at 15s in 10 μ m in vitro MT7, which we found (data not shown) requires 
luminal diffusivities at least 5 times larger than measured by Szyk et al. if uniformity of α TAT1 within 20% of 
the maximum is required. For 20 μ m long MT, at least 20 times larger diffusivities are needed. However, such 
large luminal diffusivities preclude the tip-directed acetylation we observe in vivo. Since we have no reason to 
expect luminal diffusivities to hugely differ between in vivo and in vitro MT, we conclude that uniform acetylation 
observed for in vitro MT requires rapid lateral access of α TAT1.
If defects or holes in lattice allow α TAT1 to access the lumen of MTs assembled in vitro, the same could be 
true for other macromolecules. It has been reported that antibodies targeting luminal epitopes cannot access 
to the lumen of unfixed cellular MTs18. Indeed, while fixed, Triton-extracted HeLa cell MTs showed a classi-
cal anti-acetylated K40 staining, only a background staining was detectable in unfixed conditions (Fig. 4A). In 
sharp contrast, anti-acetylated K40 staining was visible along both fixed and unfixed in vitro MTs (Fig. 4B). We 
concluded that, in unfixed conditions, the anti-acetylated K40 antibody can access the lumen of in vitro but not 
cellular MTs. Our data suggest that the shaft of in vitro MTs is leaky and allows lateral access of macromolecules 
to the lumen. This agrees with both our modelling, and the observed uniform acetylation patterns of in vitro MTs.
It has been suggested that α TAT1 could bind to the outside of MTs and that this could facilitate targeting 
the enzyme to the lumen19. Indeed, we observed by Atomic Force Microscopy that α TAT1 binds to the exterior 
face of in vitro MTs (Supplementary Figure 4). This exterior binding could enhance α TAT1 entry to the lumen 
through holes or defects in the lattice of MTs polymerized in vitro, or to the open ends of MTs polymerized 
in vivo. This raises the possible that the reported scanning behaviour of individual α TAT1 molecules does not 
occur exclusively in the lumen of MTs as previously suggested7 but also on the outer surface, facilitating α TAT1 
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entry in the lumen. Such surface scanning behaviour would not change our results or conclusions, which relate to 
the luminal availability and acetylation activity of α TAT1.
To conclude, our data suggest that in vitro assembled MTs presents holes or defects along their shaft that allow 
lateral entry of α TAT1 to the lumen. The nature of such holes and why in vitro MTs would display more holes as 
compare to cellular MTs is not clear. One possibility is that MTs growing in the cellular context would be pro-
tected from developing or acquiring lateral access-promoting defects. Along this line, dislocation defects due to 
Figure 3. Stochastic acetylation of microtubules assembled in vitro. (A) MTs assembled in vitro from HeLa 
cell-purified tubulin dimers were incubated in the presence of 4 μ M recombinant α TAT1 for the indicated time 
period before being fixed and stained for total tubulin (red) and acetylated K40 tubulin (green). Scale bar: 5 μ m. 
(B) Average fluorescence intensity distribution of total tubulin staining (red) and acetylated K40 tubulin (green) 
along MTs (MTs tip at x = 1 μ m) after a 2 min incubation period with recombinant α TAT1 as in A. Data are 
represented as mean ± S.E.M. (C) Average fluorescence intensity distribution of acetylated K40 tubulin along 
MTs (MTs tip at x = 1 μ m) after a 0 (black), 2 (red) or 4 (green) min incubation period with recombinant α TAT1 
as in A. Data are represented as mean. The S.E.M was omitted for clarity. (E,D) Theoretical average acetylation 
marks distribution along MTs (MTs tip at x = 1 μ m) after the indicated incubation period with 4 μ M α TAT1 
without (E) or with (D) allowed lateral access. Data were convoluted with a 250 nm width Gaussian point-
spread-function (PSF) to better qualitatively compare with the microscopy results. The color-coded legend 
indicates the time in minutes since entry into the unacetylated lumen begins.
www.nature.com/scientificreports/
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abrupt transition in the number of protofilaments have been reported to be twice as common in vitro as compare 
to in vivo conditions13. This raises the possibility that growth conditions for in vitro MT could be adjusted to 
Figure 4. MTs assembled in vitro are permeable to anti-acetylated K40 antibody. (A) HeLa cells were Triton-
extracted in the presence of Taxol and then fixed or not with MetOH as indicated before being stained for total 
(TUB) and acetylated tubulin (AcTUB). Scale bar: 10 μ m. (B) MTs assembled in vitro from acetylated bovine 
brain-purified tubulin dimers were stabilized with Taxol and then fixed or not with MetOH as indicated before 
being stained for total (TUB) and acetylated tubulin (AcTUB). Scale bar: 10 μ m.
www.nature.com/scientificreports/
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reduce the number of holes or defects. Alternatively, microtubule-associated proteins (MAPs) might block lateral 
holes in cellular MTs, preventing α TAT1 access to the lumen at these sites. In this case, appropriate MAPs would 
need to be included in in vitro acetylation assays to recapitulate in vivo results.
Our results demonstrate that in vitro reconstituted MTs do not recapitulate the properties of cellular MTs and 
we urge great caution in studying the effects of MT acetylation with such MTs. Based on the apparent stochastic 
acetylation pattern in vitro, it was proposed that α TAT1 controls a selective, age-dependent MT acetylation7. In 
contrast to this model, the major finding of our work is that α TAT1 controls the longitudinal spreading of acetyl-
ation marks from open MT extremities in physiological conditions. In our model, the selective acetylation of a 
subset of MTs that is observed in vivo is not primarily controlled by the stability of this subset but rather by the 
chance that a given MT would acquire α TAT1 at its extremities. MTs have been shown to contact α TAT1-rich 
structures like clathrin-coated pits and focal adhesions, two types of structures that mostly accumulate at the front 
of migrating cells12,20,21. We propose that multiple contacts between MTs and these structures would enhance 
α TAT1 acquisition by front-oriented MTs leading to the progressive acetylation of this MT subset from their 
open extremities. This selective, tip-oriented acetylation mechanism has important consequences since cell-front 
oriented acetylated MTs are instrumental in controlling directional cell migration12.
Methods
Cell culture. HeLa cells (a gift from A. Dautry, Institut Pasteur, Paris, France) were grown in DMEM, high 
glucose, GlutaMax™ supplement media, supplemented with 10% fetal calf serum at 37 °C in 5% CO2.
Antibodies and reagents. Mouse monoclonal anti-K40 acetylated tubulin (clone 6–11B1) was purchased 
from Sigma. Recombinant humanised anti-α -tubulin (clone F2C-hFc2) and Cy3-conjugated anti-human anti-
bodies were purchased from the antibody platform of the Institut Curie (Paris, France). DyLight488-conjugated 
anti-mouse antibodies were from Jackson Immunoresearch. Nocodazole was purchased from Sigma.
RNA interference. For siRNA depletion, HeLa cells were plated at 20% confluence and treated with the 
α TAT1 siRNA (25 nM; ON-TARGETplus SMARTpool, Dharmacon, Lafayette, CO, USA) using RNAiMAX trans-
fection reagent according to the manufacturer’s instruction (Invitrogen, Carlsbad, CA). Protein depletion was max-
imal after 72 h of siRNA treatment as shown by immunofluorescence analysis with anti-acetylated K40 antibodies. 
Sequences of α TAT1 siRNAs: 5′ -GUAGCUAGGUCCCGAUAUA-3′ , 5′ -GAGUAUAGCUAGAUCCCUU-3′ , 
5′ -GGGAAACUCACCAGAACGA-3′ , 5′ -CUUGUGAGAUUGUCGAGAU-3′ .
DNA constructs and protein purification. DNA sequence encoding residues 1–193 (catalytic domain) 
of mouse α TAT1 was obtained by PCR by using cDNA of C-terminally GFP-tagged mMEC17 as a template 
(Montagnac et al., Nature, 2013). PCR fragment with engineered flanking restriction sites was subcloned into 
the multi-cloning sites of pGEX4T1 (Amersham Pharmacia Biotech) to encode in-frame fusion proteins with the 
amino-terminal GST-tag. The construct was verified by double-stranded DNA sequencing. Purification of the 
recombinant protein was performed using standard protocols as described12. HeLa cell tubulin and bovine brain 
tubulin were purified as described22.
Indirect immunofluorescence. For analysis of acetylation dynamics with in vivo microtubules, HeLa cells 
plated onto coverslips were incubated in the presence of 10 μ M Nocodazole for 5 hours to induce microtubule 
depolymerisation. Cells were then washed three times in complete medium to washout Nocodazole and allow 
microtubules to re-grow. Cells were then fixed at indicated time points after washout in ice-cold methanol and 
processed for immunofluorescence microscopy by using anti-α -tubulin and anti-acetylated K40 antibodies.
For ex vivo acetylation assay, cells were washed in PEM buffer (80 mM PIPES, 1 mM EGTA, 1 mM MgCl2, 
pH 6, 8) before microtubules extraction in PEM buffer containing 1% Triton X-100 and 10 μ M Taxol. Acetylation 
reactions were performed in PEM buffer containing 10 μ M Taxol and the indicated concentration of recombinant 
α TAT1 in presence of 50 μ M acetyl coenzyme A (Sigma) at 37 °C and stopped at indicated time points by fixation 
with ice cold methanol before being processed for immunofluorescence microscopy by using anti-α -tubulin and 
anti-acetylated K40 antibodies.
For the in vitro microtubule acetylation assay, 25 μ M HeLa cell-purified tubulin was incubated in PEM buffer 
supplemented with 15% glycerol and 1 mM GTP, for 40 min at 37 °C to promote polymerization. Microtubules 
were then diluted in PEM progressively supplemented with 10 μ M taxol (Sigma). Acetylation reactions were per-
formed in PEM-Taxol buffer with 4 μ M recombinant α TAT, in presence of 50 μ M acetyl coenzyme A (Sigma) at 
37 °C and stopped at indicated time points by fixation with 2% glutaraldehyde. Microtubules were adsorbed on 
poly-L-lysine coated coverslips and processed for immunofluorescence microscopy by using anti-α -tubulin and 
anti-acetylated K40 antibodies.
For experiments with unfixed microtubules, Triton-extracted HeLa cell microtubules or microtubules 
assembled in vitro from purified bovine brain tubulin were prepared as described above and incubated with the 
anti-acetylated K40 antibody for 30 min at room temperature. For in vitro microtubules, this incubation step was 
performed in suspension before microtubules were washed and spotted on a glass coverslip. Microtubules were 
then processed for immunofluorescence microscopy as described above except that microtubules were not fixed.
Cells or microtubules were imaged with the 100× objective of a wide-field microscope DM6000 B/M (Leica 
Microsystems) equipped with a CCD CoolSnap HQ camera (Roper Scientific) and steered by Metamorph 7 
(Molecular Devices). All pictures shown are representative of at least three independent experiments.
Analysis of fluorescence distribution along microtubules. Analysis of total tubulin or acetylated K40 
tubulin signal distribution along microtubules was performed using Metamorph 7 (Molecular Devices) software 
by drawing a 4 μ m long linescan along the long axis of unambiguously individual microtubules, starting 1 μ m in 
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front of the visible tip. Total or acetylated K40 background fluorescence values were subtracted for each individual 
microtubules. At least 100 microtubules from 3 independent experiments were analysed for each time points. 
Data were pooled and expressed as mean fluorescence ± S.E.M. over distance. S.E.M. was omitted in some figures 
for clarity.
Modelling Methods. From the one-dimensional diffusion equation for the time-evolution of a linear density 
ρ(x, t) of α TAT1 in the MT lumen,
ρ ρ∂
∂
= ∂ ∂
x t
t
D x( , ) / , (1)
2 2
the solution23 is
ρ ρ=





x t
x
Dt
( , ) erfc
4
,
(2)0
where the position x ≥ 0 is measured from the end of the MT and the time t ≥ 0 is measured from when α TAT1 
is added. Here ρ0 represents the steady-state luminal concentration of α TAT1 that results from whatever bulk 
concentration is imposed from outside the MT. This differs slightly from the model of Szyk et al., since they used a 
fixed length MT open at both ends7. In addition, Szyk et al. did not consider acetylation or lateral entry of α TAT1 
in their quantitative model7.
We model the acetylation as a local density of available sites a(x, t) that are acetylated by locally available α 
TAT1, so that
ρ∂
∂
= Γ −
a x t
t
x t a a( , ) ( , )( ) (3)0
where Γ is our acetylation rate. This is easily solvable in closed form, and defining ≡aˆ a a/ 0 and ≡z x Dt/ 4  we 
obtain
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2 2
To model the effects of lateral entry of α TAT1 into the MT lumen, through transient or static holes, we assume 
uniform entry so that
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where the rate γ captures the size, density, frequency, and lifetime of holes that allow α TAT1 entry. The 
closed-form solution is
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We see that as γ → ∞ , we immediately impose the steady-state luminal concentration ρ = ρ0. When γ > 0, we 
solve for the time-dependent acetylation numerically to obtain aˆ x t( , )-note that the spatial-dependence of aˆ  will 
no longer be simply in terms of ≡z x Dt/ 4 .
To evaluate our analytical and numerical results, we need to determine the diffusivity D, the lateral entry rate 
γ, and the combination ρΓ 0. Since acetylation is reported in arbitrary units, we do not need an explicit value of 
a0–i.e. we plot ≡aˆ a a/ 0.
Szyk et al. determined D = 0.27 μm2/s from tracking of individual fluorescently-labeled α TAT1 in the MT 
lumen7. D is approximately 100x smaller than the geometrically hindered diffusivity Dhindered = 26.3 μm2/s 
expected for a particle the size of α TAT1 in the tube-like MT geometry7. This difference is due to the reversible 
binding of α TAT1 to the MT24, with D = α Dhindered. The correction factor α is the duty-factor, or the proportion of 
time that α TAT1 is unbound and diffusing. The 100x reduced D results from α TAT1 being almost always immo-
bilized with α ≈ 0.01. Crucially, a key assumption is that the binding kinetics are “faster than diffusion transport 
rates”24. From the video microscopy of Szyk et al., no immobilized α TAT1 is apparent by eye. This implies very 
fast binding/unbinding within the lumen, with τ . s0 1unbind , which is consistent with the assumptions of Odde 
and Crank for length-scales greater-than τ µ= ≈ . D m0 1unbind .
Szyk et al. determined a lifetime τ = 1.5 s of α TAT1 “interaction” in the MT lumen (see their Fig. 5c). However, 
τ cannot be a transition between D and Dhindered, since D = 0.27 μm2/s already includes the effects of binding/
unbinding and we have already seen that binding and unbinding are relatively fast. Instead, we interpret τ as a 
lifetime of residence in the MT lumen. We believe τ represents the rate of escape from the MT lumen, and so also 
determines the lateral entry rate γ = =
τ
min40/1 . Finally, Shida et al. determined kcat = 615± 34× 10−6 s−1 for 
1 μM bulk α TAT14. We take Γ ρ0 = 4 kcat = 0.15/min, corresponding to our 4 μM bulk α TAT1.
Atomic Force Microscopy. As described above microtubules polymerization was promoted by incubating 
tubulin in PEM buffer supplemented with 15% glycerol and 1 mM GTP, for 40 min at 37 °C to. Microtubules were 
then diluted in PEM supplemented with 10 μ M taxol. Experiments with α TAT were carried out in PEM-Taxol 
buffer with 400 nM recombinant α TAT1 at 37 °C.
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5 μ l of microtubules aliquot (with and without α TAT1) were deposited on mica surface pretrated with 100 μ M 
spermidine25 and incubated for typically 20 s, which allows the diffusion of microtubules on the surface and their 
adsorption26. The mica surface was then plunged for 30s in uranyl acetate solution (0.02% w/v) for microtubules 
fixation on mica surface. Finally, the sample was rinsed with pure water (Millipore) and dried with a filter paper. 
AFM imaging was carried out in Tapping Mode, with a Multimode system (Bruker) operating with a Nanoscope 
V controller (Bruker). We used silicon AC200TS cantilevers (Olympus) with resonance frequencies around 
150 kHz. All images were collected at a scan frequency of 1 Hz and a resolution of 2048 × 2048 pixels. Images were 
analysed with Nanoscope V software, and a third-order polynomial function was used to remove the background.
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